StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.24−0.16 (-6.67%)

Close on Nov 16, 2026Market cap $5.06MP/E –Yield –

Biodexa Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2023 it was -2103.4%, against -1277.8% the year before. The highest annual figure on record is -609.6% in fiscal 2018.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-2103.4%−825.6
FY2022Dec 31, 2022-1277.8%−67.1
FY2021Dec 31, 2021-1210.7%+5506.5
FY2020Dec 31, 2020-6717.2%−5038.0
FY2019Dec 31, 2019-1679.2%−1069.6
FY2018Dec 31, 2018-609.6%+732.7
FY2017Dec 31, 2017-1342.4%−612.8
FY2016Dec 31, 2016-729.6%+209.9
FY2015Dec 31, 2015-939.5%–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?